IV Disinfecting Caps Market - Top Companies and Manufacturers

  • Report ID: 4101
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Companies Dominating the IV Disinfecting Caps Landscape

top-features-companies
    • Human Metabolome Technologies America Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.    
    • Bio-Rad Laboratories, Inc.
    • Biocrates life sciences AG
    • Agilent Technologies, Inc.                       
    • Merit Medical Systems
    • B. Braun Melsungen AG
    • ICU Medical, Inc.
    • Becton, Dickinson and Company
    • 3M Company

Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fisher Scientific Inc. introduced TrueMark Infectious Disease Research Panels to identify and classify bacteria that cause gastrointestinal, respiratory, vaginal, urinary, and sexually transmitted diseases quickly and accurately. Further, researchers can choose from more than 90 different bacterial and viral strain assays using the predefined and programmable panel options.

  • Biocrates life sciences AG a global leader in targeted metabolomics, acquired Metanomics Health GmbH to offer focused metabolomics profiling services, personalized assays, targeted screening kits, and in-depth data interpretation.

 

 


Author Credits:  Radhika Pawar


  • Report ID: 4101
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of IV disinfecting caps is estimated at USD 423.51 Billion.

The IV disinfecting caps market size was valued at USD 387.9 Billion in 2023 and is likely to cross USD 1.37 Trillion by the end of 2036, registering more than 10.2% CAGR during the forecast period i.e., between 2024-2036. Growing health awareness and the rising geriatric population are the major factors driving the market growth.

North America is expected to account for majority industry share by 2036, attributed to growing number of surgeries.

Human Metabolome Technologies America Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Biocrates life sciences AG, Agilent Technologies, Inc., Merit Medical Systems, B. Braun Melsungen AG, ICU Medical, Inc., Becton, Dickinson and Company, 3M Company
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying